cisatracurium besylate

Generic: cisatracurium besylate

Labeler: hospira, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cisatracurium besylate
Generic Name cisatracurium besylate
Labeler hospira, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

cisatracurium besylate 10 mg/mL

Manufacturer
Hospira, Inc.

Identifiers & Regulatory

Product NDC 0409-1103
Product ID 0409-1103_0ec666c8-db68-4a59-9da4-e0abd8e209c5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203236
Listing Expiration 2026-12-31
Marketing Start 2019-12-02

Pharmacologic Class

Classes
neuromuscular nondepolarizing blockade [pe] nondepolarizing neuromuscular blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04091103
Hyphenated Format 0409-1103

Supplemental Identifiers

RxCUI
199211 199212 1730194
UNII
80YS8O1MBS

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cisatracurium besylate (source: ndc)
Generic Name cisatracurium besylate (source: ndc)
Application Number ANDA203236 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1103-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-1103-11)
source: ndc

Packages (1)

0409-1103-01 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1103-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-1103-11)

Ingredients (1)

cisatracurium besylate (10 mg/mL)

Linked Drug Pages (1)

Cisatracurium Besylate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "0ec666c8-db68-4a59-9da4-e0abd8e209c5", "openfda": {"unii": ["80YS8O1MBS"], "rxcui": ["199211", "199212", "1730194"], "spl_set_id": ["67908e20-044d-454d-9c51-bf106e817bd0"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1103-01)  / 20 mL in 1 VIAL, SINGLE-DOSE (0409-1103-11)", "package_ndc": "0409-1103-01", "marketing_start_date": "20191202"}], "brand_name": "Cisatracurium Besylate", "product_id": "0409-1103_0ec666c8-db68-4a59-9da4-e0abd8e209c5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "0409-1103", "generic_name": "CISATRACURIUM BESYLATE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "10 mg/mL"}], "application_number": "ANDA203236", "marketing_category": "ANDA", "marketing_start_date": "20191202", "listing_expiration_date": "20261231"}